Robin E. Frink

Statistics

Publications

Citations

328

H-Index

Active since

2014

Affiliations

The University of Texas Southwestern Medical Center(Current)

Robin E. Frink is an author at The University of Texas Southwestern Medical Center specializing in medicine, malignant neoplasms, and molecular oncology.

Publications per year

2014–2016

Publications

XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer

Jimi Kim, Elizabeth A. McMillan, Hyun Seok Kim et al. · Nature · 2016 · 209 citations · Full text

Medicine, Cancer Biology, Oncology +16

Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner

Robin E. Frink, Michael Peyton, Joan H. Schiller et al. · Oncotarget · 2016 · 61 citations · Full text

Medicine, Oncology, Pharmacology +15

Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non–Small Cell Lung Cancer and Its Potential as a Circulating Biomarker

Tzu‐Fang Lou, Deepa Sethuraman, Patrick Dospoy et al. · Cancer Prevention Research · 2015 · 43 citations

Medicine, Cancer Biology, Oncology +17

Abstract 1747: BGB324, a selective small molecule Axl kinase inhibitor to overcome EMT-associated drug resistance in carcinomas: Therapeutic rationale and early clinical studies

Katarzyna Wnuk-Lipińska, Crina Tiron, Gro Gausdal et al. · Cancer Research · 2014 · 15 citations

Medicine, Oncology, Pharmacology +17

1–4 of 4